Over recent years the secreted guidance cue, netrin-1, and its receptor, DCC, have been shown to be an essential guidance system driving axon path®nding within the developing vertebrate central nervous system (CNS). Mice lacking DCC exhibit severe defects in commissural axon extension towards the¯oor plate demonstrating that the DCC-netrin guidance system is largely responsible for directing axonal projections toward the ventral midline in the developing spinal cord (Fazeli et al., Nature 386 (1997) 796). In addition, these mutants lack several major commissures within the forebrain, including the corpus callosum and the hippocampal commissure. In contrast to the CNS, the role of the DCC guidance receptor in the development of the mammalian peripheral and enteric nervous systems (PNS and ENS) has not been investigated. Here we demonstrate using immunohistochemical analysis that the DCC receptor is present in the developing mouse PNS where it is found on spinal, segmental, and sciatic nerves, and in developing sensory ganglia and their associated axonal projections. In addition, DCC is present in the ENS throughout the early developmental phase. q
Results and discussion
As a ®rst step in addressing DCC function in the embryonic peripheral and enteric nervous systems (PNS and ENS) we have carried out an immunohistochemical analysis from embryonic day 10.5 (E10.5) to E16.0 using an anti-peptide antiserum raised against a unique C-terminal peptide of mouse DCC. At E10.5, DCC protein could be detected in several regions of the embryo including the population of commissural axons migrating ventrally to the¯oor plate within the early neural tube, as has been previously described (Keino-Masu et al., 1996) (Fig. 1A, arrows) . In addition, low levels of DCC protein were detected on motor axons extending from the ventral neural tube (Fig. 1A,  arrowheads) . Expression of the DCC orthologue in both Caenorhabditis elegans and Drosophila melanogaster has previously been described on motor axons Kolodziej et al., 1996) . By E11.5, DCC protein was present at low levels on axons projecting within the dorsal roots of dorsal root ganglia (DRGs) (Fig. 1B, arrows) throughout the rostro-caudal axis of the neural tube and in the spinal nerves. In the E12.5 embryo, DCC protein was seen on the spinal nerves, the lumbar nerve trunk, and also on the sciatic and segmental nerves (Fig. 1C) . Pre-incubation of the antiserum with the immunizing peptide resulted in the loss of immunoreactivity demonstrating the speci®-city of the antiserum (Fig. 1D , inset in Fig. 1A) .
DCC protein was also observed in sensory ganglia and nerves extending from them. At E10.5 faint but signi®cant immunostaining was seen in the early trigeminal (V) ganglion ( Fig. 2A,B, arrows) . In contrast, no DCC could be detected in the facio-acoustic (VII±VIII) neural crest complex. In addition, within the central nervous system (CNS) high levels of DCC staining were observed on the ®bres present at the lateral margin of the hindbrain neuroepithelium ( Fig. 2A, arrowheads) . By E14.5 high levels of DCC protein were present in the central root of the trigeminal nerve (Fig. 2C , arrow) and in the maxillary subdivision of the trigeminal nerve (Fig. 2C, arrowhead) . Within the CNS, intense DCC immunostaining was observed in the diencephalon and pons at E14.5 ( Fig. 2C ) and in the medulla at E12.5 (Fig. 2E) . DCC was also seen on nerves associated with the glossopharyngeal (IX) ganglion (E11.5, Fig. 2D , arrowheads), the superior and inferior vagal (X) ganglia (E11.5, Fig. 2D , arrows; E12.5, Fig. 2E , arrows), and the vestibulocochlear (VIII) ganglion (E12.5, Fig. 2E , arrowheads). For all these ganglia, only weak immunostaining was observed on the neural cell bodies within each ganglia indicating that the vast majority of the DCC receptor is transported into the axon shaft after synthesis. Fig. 3 demonstrates that DCC protein was seen at high levels in the myenteric plexi of the E16.0 stomach (Fig.  3A ,B, arrows) and midgut (Fig. 3C,D, arrows) . The ENS is established in the gastrointestinal tract by neural crest cells that migrate in a rostro-caudal direction through the gut mesenchyme between E9.5 and E14.5 (Young et al., 2000) . Neural crest-derived cells are ®rst detected in the embryonic stomach at E9.5±E10.5. One day later, we observed a population of DCC-positive cells within the mesenchyme of the E11.5 stomach at a position expected for early neural crest-derived cells (Fig. 3E,F, arrows) . The earliest neural precursors appear in the midgut by E11.5. DCC-positive cells were ®rst seen in the midgut mesenchyme at E12.5 (Fig. 3G,H, arrows) . Since DCC expression has not been reported in glial cells, we suggest that the DCC-positive cells in the E11.5 stomach and E12.5 midgut are early enteric neurons.
In summary, we have demonstrated that DCC has a broad expression pattern within the developing PNS where it is present on peripheral nerves including the nerves associated with sensory ganglia. In addition, the DCC receptor is also expressed in the developing ENS suggesting that DCC is likely to play a role in the development of the ENS. Thus, it would be of great interest to examine the DCC loss-of-function mice (Fazeli et al., 1997) for axon path®nding and migrational defects in the PNS and ENS.
Materials and methods
The rabbit polyclonal antiserum was raised against the C-terminal peptide (SEESHKPTEDPASV) corresponding to amino acids 1406±1419 of the mouse DCC protein Fig. 1 . Localization of DCC protein in the developing mouse PNS. DCC protein is present at low levels on motor axons in the ventral root at E10.5 (A, arrowheads; transverse, dorsal is to the left). At E11.5, DCC protein could be detected on axons within the dorsal roots of the DRGs (arrows) and in the spinal nerves (spn) (B, saggital, dorsal is to the right, rostral is to the top). At E12.5 DCC protein was present on the axons comprising the spinal nerves, the lumbar nerve trunk (lnt), the sciatic nerves (sc), as well as the segmental nerves (sgn) (C, oblique, transverse, the rostral neural tube is to the left, the caudal neural tube is to the right). Pre-incubation of the antiserum with the immunizing peptide resulted in the loss of immunoreactivity (D, inset in A). nt, neural tube; mn, motor neurons. Scale bars: (A) 23 mm; (B) 47 mm; (C,D) 237 mm. Fig. 2 . DCC is present on nerves associated with sensory ganglia. Low levels of DCC protein were found in the early trigeminal ganglion (v) at E10.5 (A,B, arrows, horizontal section, anterior is to the left). (B) is a higher magni®cation image of the boxed region in (A). At E14.5, high levels of DCC were localized to the central root of the trigeminal nerve (arrow) and to the maxillary subdivision of the trigeminal nerve (arrowhead) (C). At E11.5, DCC protein was present on nerves extending from the glossopharyngeal (ix) ganglion (arrowheads) and the superior and inferior vagal (x) ganglia (arrows) (D, saggital, rostral is to the top). Axons extending from the superior and inferior vagal (x) ganglia (arrows) and the vestibulocochlear (viii) ganglion (arrowheads) have signi®cant levels of DCC protein at E12.5 (E). Pre-incubation with the peptide antigen resulted in loss of immunoreactivity (F, inset in B) . co, cochlear; di, diencephalon; md, mandible; mo, medulla oblongata; mx, maxilla; ne, neuroepithelium; on, optic nerve; ov, otic vesicle; pn, pons; sa, saccule; 1ba, ®rst branchial arch; vii± viii, facio-acoustic complex. Scale bars: (A) 83 mm; (B) 21 mm; (C) 213 mm; (D) 107 mm; (E,F) 67 mm. (Cooper et al., 1995) . Speci®c antibody was detected using a secondary HRP-goat anti-rabbit Ig (Zymed, CA) which was visualized using the DAB Substrate Chromagen Kit (Dako, CA). To demonstrate the speci®city of the antiserum, diluted antiserum (1:200) was pre-incubated with the peptide antigen (20 mg/ml) for 30 min before adding to sections. Fig. 3 . DCC is present in the developing ENS. At E16.0 DCC protein can be seen within the myenteric plexi of the developing stomach (A,B, arrows) and midgut (C,D, arrows) . DCC protein can also be seen in early neural crest-derived cells residing in the mesenchyme of the E11.5 stomach (E,F, arrows) and midgut (G,H, arrows) . (B,D,F,H) are higher magni®cation images of the boxed regions in (A,C,E,G), respectively. Pre-incubation with the peptide antigen resulted in loss of immunoreactivity (insets in F,H). cm, inner circular muscle; ep, epithelium; gm, gastric mucosa; lm, outer longitudinal muscle; Lv, liver; mp, myenteric plexus; mg, midgut; sto, stomach; ur, urogenital ridge. Scale bars: (A) 88 mm; (B,D) 22 mm; (C,E,G) 107 mm; (F,H) 26 mm.
